Corrigendum: Case report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer
- Resource Type
- article
- Source
- Frontiers in Oncology, Vol 13 (2023)
- Subject
MAP2K1 MEK panitumumab resistance mechanisms colorectal cancer Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 - Language
- English
- ISSN
- 2234-943X